Sodium-glucose co-transporter-2 inhibitors and sacubitril/valsartan combination in patients with heart failure with reduced ejection fraction; does it deserve our attention? Patoulias D, Papadopoulos C, Doumas M. Am Heart J 2021;236:104-105.

Read + Share

Amedeo Smart

Independent Medical Education